pistoia-pgo

is a Ontology.

The Pistoia Alliance Pharma General Ontology (PGO) is a collaborative initiative to provide a shared upper-level reference ontology for the pharmaceutical industry. PGO aims to serve as a "Rosetta Stone" enabling semantic interoperability within and across organizations by identifying key concepts used throughout the drug development lifecycle and selecting public resources that can provide identifiers for each concept. Rather than creating new ontologies or mandating specific terminologies, PGO focuses on providing clear mechanisms to enable unambiguous declaration of the resources used and capturing the criteria for selecting semantic artifacts. The project follows FAIR principles and reuses existing semantic resources, including ontologies and controlled terminologies, as well as open source community software. The initial phase focuses on Research & Development (R&D) operations, defining core concepts and recommendations for associating controlled terminologies to service data exchange among pharmaceutical industry stakeholders. PGO is developed using LinkML for representing and documenting each type, and is supported by a consortium of major pharmaceutical companies including AstraZeneca, Chiesi Group, GSK, Merck KGaA, Novo Nordisk, Pfizer, and Hoffmann-La Roche.

Domains

drug discovery, general

License

CC BY 4.0

Homepage

pistoia-pgo

Repository

GitHub

External IDs

No external IDs available

Product Summary

Contacts

Products

From this Resource
ID Name URL Category Format Description
pistoia-pgo.github PGO GitHub Repository Pistoia-Alliance-PGO Ontology http GitHub repository containing the PGO ...
pistoia-pgo.documentation PGO Documentation Website Pistoia-Alliance-PGO Documentation http Documentation website for PGO includi...
pistoia-pgo.core_concepts PGO Core Concepts (Version 1.0) 2025_PGO_V1.0_core_concepts.md (16.2 KB) Documentation txt Markdown list of the PGO Version 1.0 ...
pistoia-pgo.core_concepts_csv PGO Core Concepts CSV (Version 1.0) PGO_V1.0_core_concepts_2026-03-20.csv (11.0 KB) Product csv CSV release of the PGO Version 1.0 co...
pistoia-pgo.core_concepts_xlsx PGO Core Concepts Excel (Version 1.0) PGO_V1.0_core_concepts_2026-03-20.xlsx (22.8 KB) Product xlsx Excel release of the PGO Version 1.0 ...
pistoia-pgo.use_cases PGO Use Cases pharma-general-ontology-use-cases Documentation http High-level use cases demonstrating PG...
pistoia-pgo.project_page PGO Project Page pharma-general-ontology Documentation http Pistoia Alliance project page for PGO...

Details

Description

The Pistoia Alliance Pharma General Ontology (PGO), also called PGO-Terminology, is a collaborative Pistoia Alliance project to agree on a shared set of core concepts for pharmaceutical research and development and to recommend public vocabularies that can supply identifiers for each concept.

Overview

PGO addresses the insufficient and ambiguous asset descriptions that hamper information exchange within and across pharmaceutical organizations. Rather than mandating one resource over another, PGO aims to make it clear which controlled terminologies are used and why. Phase 1 started in April 2024 and focused on research and early development (R&ED).

The Version 1.0 core concept list contains 17 concepts: Assay, Biomarker, Biospecimen, Cell, Clinical study, Clinical study site, Compound, Device, Disease, Drug, Gene, Indication, Pharmaceutical product, Protein, Species, Substance, and Unit. Each concept has a recommended definition reused from an existing resource, mostly the NCI Thesaurus, with others taken from OBI, MeSH, ChEBI, PSI-MI, UniProt, and QUDT, along with the date the PGO steering committee approved it and examples of candidate sources.

Key Features

  • Core Concepts: Defines essential entities most frequently used when exchanging pharmaceutical R&D data
  • Reused Definitions: Recommended definitions come from existing public resources, with source identifiers and attribution
  • Controlled Terminologies: Aims to specify value sets for key attributes using community-agreed resources
  • FAIR Principles: Follows Findable, Accessible, Interoperable, and Reusable data management principles
  • LinkML: The project uses LinkML to represent and document each type

Project Roadmap

Phase 1 (2024-2025):

  • Process flow, expert identification, and candidate definitions of core concepts
  • Identification of high-level use cases
  • Expert consultation, alignment, and formalization of core concepts for R&ED
  • Implementation and testing using LinkML
  • First release of the recommended core concepts

Phase 2 (2025-2026):

  • Field testing and application
  • Extension of the core-concept vocabulary
  • Updated version of the core-concept vocabulary
  • Machine-readable version of PGO-Terminology

Project Sponsors

Phase 1 sponsors listed in the repository are AstraZeneca, Chiesi Group, GSK, Merck KGaA, Novo Nordisk, Pfizer, and Roche. The Pistoia Alliance project page also lists Vertex as a supporter.

Contacts

  • Pistoia Alliance (https://www.pistoiaalliance.org/)
  • Giovanni Nisato (Project Manager)
  • Philippe Rocca-Serra (Technical Lead)

Products

Publications


This resource was manually curated for the Knowledge Graph Registry.

Is this information incorrect or incomplete? Request an update.

Created: November 10, 2025 | Last modified: November 10, 2026